StockData
Bausch Health Companies Inc. logo

Bausch Health Companies Inc. (BHC) income statement

BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3076% below fair value
$8.73+0.26 (+3.07%)

Close on Nov 18, 2026Market cap $3.27BP/E –Yield –

Bausch Health Companies Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
11.2%
Net margin
-7.6%
Return on equity, FY2025
-17.1%

Financial strength

Current ratio
1.56
Debt to equity
-15.54
Debt to assets
81.0%
Cash to current liabilities
52.3%

Valuation

P/E ratio
–
Price to sales
0.29
Price to book
–
Dividend yield
–

See a number that looks wrong?